Form 4: Biogen Executive Sean Godbout Trades Shares

Biogen Inc. Chief Accounting Officer Sean Godbout reported transactions involving company stock and restricted stock units.

Summary

• Sean Godbout, Chief Accounting Officer at Biogen Inc., reported a disposition of 54 shares of common stock on April 1, 2026, at a price of $183.78 per share.
• Godbout also acquired 181 shares of common stock on April 1, 2026, with no cost indicated, and reported 1,395.6667 shares beneficially owned.
• Additionally, 181 restricted stock units were acquired on April 1, 2026, with a vesting schedule starting on the first anniversary of the grant date (April 1, 2025) over three equal yearly installments, with the next vesting date being April 1, 2028.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions with both acquisitions and dispositions of stock, without a clear indication of strong positive or negative sentiment.

Positives

• Sean Godbout acquired 181 shares of common stock, indicating continued investment or compensation.
• The acquisition of restricted stock units suggests a long-term incentive plan for management.

Negatives

• Sean Godbout disposed of 54 shares of common stock at $183.78 per share.

Future Outlook

The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of April 1, 2025.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company executives and directors. These transactions can offer insights into management's confidence in the company's future prospects.

Stakeholder Impact

• Shareholders: The disposition of shares by an executive may be interpreted by some shareholders as a signal, though the simultaneous acquisition of other shares and RSUs suggests a mixed or neutral outlook.
• Employees: The vesting of restricted stock units reinforces the company's incentive structure for key personnel.
• Management: The transactions reflect standard compensation and equity management practices for senior executives.

Next Steps

• Vesting of restricted stock units over the next three years.

Key Dates

Keywords

Form 4, SEC Filing, Biogen Inc., BIIB, Sean Godbout, Insider Trading, Stock Transaction, Restricted Stock Units, Beneficial Ownership